Address
Other Office
450 Newport Center Drive
Suite 600
Newport Beach, CA 92660
United States
Phone
Website
Recent investment activity
KANDO id: 32063
Corporate information
Official name
Versant Ventures Management LLC
Registration country
Company type
Venture capital firm focused on making investments in the healthcare and biotechnology industries.Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 51 - 75 of 129| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Lutonix Inc | A medical device company that has developed Moxy, a new drug-coated balloon catheter for peripheral and coronary interventions. | N/A | |||
|
|
Metabolex Inc | Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. | N/A | |||
|
|
Metabolex Inc | Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. | Series D | |||
|
|
Microfabrica Inc | Microdevice manufacturer | N/A | |||
|
|
Minerva Surgical Inc | N/A | ||||
|
|
NeoGuide Systems Inc | N/A | ||||
|
|
Neurotech Pharmaceuticals Inc (Neurotech Inc) | Cell-based drugs for diseases of the eye. | Series B | |||
|
|
NewHope Bariatrics Inc | N/A | ||||
|
|
Nexis Vision Inc | N/A | ||||
|
|
NovaCardia Inc | Cardiovascular pharmaceutical company focused on the development and commercialization of novel clinical stage drug candidates. | N/A | |||
|
|
Novasys Medical Inc | Develops innovative therapies in women's health with an initial focus on the development and commercialization of the Renessa System | N/A | |||
|
|
Okairos AG | Series B | ||||
|
|
Okairos SRL | N/A | ||||
|
|
OpGen Inc | Provider of Whole Genome Mapping technologies for high-precision microbial analysis markets. | N/A | |||
|
|
OraMetrix Inc | Provider of innovative 3-D technology solutions facilitating and improving the quality of orthodontic care. | N/A | |||
|
|
Panmira Pharmaceuticals LLC | Pharmaceutical company for inflammatory diseases. | N/A | |||
|
|
ParAllele BioScience Inc | N/A | ||||
|
|
Pathwork Diagnostics Inc | N/A | ||||
|
|
Pharmion Corp | Initially, Pharmion concentrated its efforts on licensing products in the areas of hematology, oncology and supportive care. | N/A | |||
|
|
PhaseRx Inc | Develops novel approaches to the delivery of siRNA and other macromolecules | N/A | |||
|
Portaero Inc | N/A | ||||
|
Quanticel Pharmaceuticals Inc | Drug discovery company committed to the development of breakthrough medicines for the treatment of cancer. | N/A | |||
|
|
RedBrick Health Corp | Series C | ||||
|
|
Reliant Pharmaceuticals Inc | American heart drug specialist company. | N/A | |||
|
|
Rennovia Inc | Developing processes to make high-value known chemicals derived from renewable bio sources that have both financial and green advantages | N/A |